White label ELPA - ClinicalTrials.eu

Study on Fluid Therapy and Noradrenaline for Low Blood Pressure in Breast Reconstruction Surgery Patients

Not recruiting

3 1 1 1
Investigated Drugs:
Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End-Stage Kidney Disease on Hemodialysis

Not recruiting

3 1 1
Investigated Diseases:
- Hyperparathyroidism secondary
Investigated Drugs:
- Upacicalcet Sodium Hydrate
Study on the Effects of Samuraciclib and Elacestrant for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Samuraciclib
- Elacestrant
Study on the Effectiveness and Safety of PLS240 for Treating Secondary Hyperparathyroidism in Patients with End Stage Kidney Disease on Hemodialysis

Not recruiting

3 1
Investigated Diseases:
- Hyperparathyroidism secondary
Investigated Drugs:
- Upacicalcet Sodium Hydrate
Study on the Safety and Effects of SAR442501 for Children with Achondroplasia

Not recruiting

2 1 1
Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated Drugs:
- (Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate
+1
Study of Fulvestrant and Samuraciclib for Patients with Advanced HR Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
- Samuraciclib
- Fulvestrant
Study of GS-5718 for Patients with Cutaneous Lupus Erythematosus (CLE)

Not recruiting

2 1
Investigated Diseases:
- Cutaneous lupus erythematosus
Investigated Drugs:
- Gs-5718-03
Study Comparing Odronextamab and Lenalidomide with Rituximab and Lenalidomide for Patients with Relapsed/Refractory Follicular and Marginal Zone Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+2
Safety Study of Efgartigimod in Adults with Primary Sjögren’s Syndrome

Not recruiting

2 1 1 1
Investigated Diseases:
- Sjogren’s syndrome
Investigated Drugs:
- Efgartigimod Alfa

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies